Gordon B. Mills, M.D., Ph.D., is the new director of precision oncology at the OHSU Knight Cancer Institute. His role will be to provide an “integrative force” across various efforts in progress at the institute, including the Cancer Early Detection Advanced Research (CEDAR) Center, immuno-oncology and the system biology groups. In this video, Mills talks about the next revolution in cancer science.
